Royal Bank of Canada’s Medtronic MDT Stock Holding History

Royal Bank of Canada’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-400,000	Closed	-$35.9M	–	7215
2025 Q1	$35.9M	Buy	+400,000	New	+$35.8M	0.01%	957
2024 Q4	–	Sell	-22,200	Closed	-$2M	–	7098
2024 Q3	$2M	Buy	+22,200	New	+$1.87M	﹤0.01%	3003
2022 Q2	–	Sell	-1,115,600	Closed	-$124M	–	7571
2022 Q1	$124M	Buy	1,115,600 +500,700	+81%	+$52.9M	0.03%	435
2021 Q4	$63.6M	Buy	614,900 +577,700	+1,553%	+$66.9M	0.01%	710
2021 Q3	$4.66M	Sell	37,200 -300	-0.8%	-$38.8K	﹤0.01%	2348
2021 Q2	$4.66M	Buy	+37,500	New	+$4.71M	﹤0.01%	2362
2020 Q2	–	Sell	-30,000	Closed	-$2.71M	–	6786
2020 Q1	$2.71M	Buy	+30,000	New	+$3.19M	﹤0.01%	2244
2019 Q3	–	Sell	-2,700	Closed	-$263K	–	6938
2019 Q2	$263K	Buy	2,700 +2,500	+1,250%	+$228K	﹤0.01%	4298
2019 Q1	$18K	Buy	200 +100	+100%	+$8.95K	﹤0.01%	5700
2018 Q4	$9K	Buy	+100	New	+$9.35K	﹤0.01%	5939
2018 Q3	–	Sell	-25,000	Closed	-$2.14M	–	6852
2018 Q2	$2.14M	Hold	25,000	–	–	﹤0.01%	2674
2018 Q1	$2.01M	Buy	+25,000	New	+$2.06M	﹤0.01%	2682
2017 Q3	–	Sell	-46,400	Closed	-$4.12M	–	6859
2017 Q2	$4.12M	Buy	46,400 +19,600	+73%	+$1.65M	﹤0.01%	2079
2017 Q1	$2.16M	Sell	26,800 -513,800	-95%	-$40.1M	﹤0.01%	2493
2016 Q4	$38.5M	Buy	540,600 +468,000	+645%	+$36.8M	0.02%	652
2016 Q3	$6.27M	Hold	72,600	–	–	﹤0.01%	1761
2016 Q2	$6.3M	Sell	72,600 -1,552,900	-96%	-$126M	﹤0.01%	1756
2016 Q1	$122M	Buy	+1,625,500	New	+$122M	0.08%	197
2014 Q4	–	Sell	-175,800	Closed	-$10.9M	–	6247
2014 Q3	$10.9M	Hold	175,800	–	–	0.01%	1169
2014 Q2	$11.2M	Buy	+175,800	New	+$10.7M	0.01%	1161
2013 Q3	–	Sell	-209,400	Closed	-$10.8M	–	6190
2013 Q2	$10.8M	Buy	+209,400	New	+$10.4M	0.01%	998

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's MDT Position: Q1 2026 in Review

Royal Bank of Canada increased its Medtronic (MDT) stake by 1.4% in Q1 2026, buying an estimated $18.3M and bringing the position to 14,179,817 shares worth $1.23B. The position accounts for 0.22% of the portfolio, ranked #83.

Royal Bank of Canada first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.54B in Q3 2021. 2,239 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Royal Bank of Canada held 14,179,817 shares of Medtronic worth $1.23B as of Q1 2026.
Royal Bank of Canada bought 190,987 Medtronic shares in Q1 2026, an estimated $18.3M.
Medtronic made up 0.22% of Royal Bank of Canada's portfolio in Q1 2026, its #83 holding.
Royal Bank of Canada first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Medtronic position peaked at $1.54B in Q3 2021.
2,239 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.